Solventum Corporation (SOLV) — 分析摘要
Solventum Corporation（SOLV）的市值为14.52十亿美元，最近一年的营收同比增长了+0.9%。净利润率为18.7%。当前市盈率为10.1倍。
核心要点
- 营收同比变化+0.9%
- 净利润率18.7%
- 市盈率10.1倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比，SOLV的营收增长为+0.9%，市盈率为10.1倍。
Solventum Corporation (SOLV)
前收盘价 2026-10-12 · 市场数据 POLYGON · 财务数据 SEC EDGAR
红旗与风险提示重点关注
当前存在需要关注的风险信号，应与估值结果一并解读。
最新报表显示自由现金流为负。
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
20,000
总部
EAGAN, MN
Exchange
XNYS
需要至少 3 年年度财务数据来评估竞争壁垒。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。